Dr. Christopher Bednarz, MD

Dr. Bednarz practices at Richmond VA Medical Center in Richmond, Virginia, part of Veterans Health Administration.

Dr. Bednarz's NPI, 1467010595, was assigned on June 4, 2019. Dr. Bednarz graduated from Virginia Commonwealth University School of Medicine in 2018. Dr. Bednarz holds Connecticut license 78747.

Dr. Bednarz's primary practice is Richmond VA Medical Center, at 1201 Broad Rock Boulevard, Richmond, VA 23249 in Richmond City. The practice phone is (804) 675-5000.

Dr. Bednarz's primary practice is Richmond VA Medical Center in Richmond, Virginia, part of Veterans Health Administration. Dr. Bednarz is also affiliated with Greenwich Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Bednarz to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bednarz practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Bednarz's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Bednarz's licenses on file in 2 states: Connecticut and Wisconsin.

CMS data shows 91 Medicare services from Dr. Bednarz across 3 procedure codes in 2024, for 45 Medicare patients. Medicare paid $4,940 for them. Every service was in an office.

CMS counts 45 Medicare patients who saw Dr. Bednarz in 2026. The largest group is 75 to 84, with 20 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bednarz's median patient age at 71, with 27% women.

In 2026, Dr. Bednarz wrote 58 Medicare Part D claims for 44 patients. 88% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $406 in total drug cost. In 2023, CMS named 37 claims across 2 drugs.

Dr. Bednarz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bednarz as offering telehealth. CMS counts 28 procedures of prostate resection by Dr. Bednarz, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Bednarz, published from 2022 to 2023. 2023 was the busiest year, with 2. Dr. Bednarz's most frequent co-authors are Linda S. Burkett, MD, Lance J. Hampton, MD and Adam P. Klausner, MD.

CMS Open Payments shows 57 general payments to Dr. Bednarz from 6 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 65% of the total. Boston Scientific Corporation paid the most, $1,825.

Dr. Bednarz graduated from Virginia Commonwealth University School of Medicine in 2018.